# Bolus Versus Continuous Infusion of Meropenem

> **NCT03452839** · PHASE4 · COMPLETED · sponsor: **Università Vita-Salute San Raffaele** · enrollment: 607 (actual)

## Conditions studied

- Antibiotic Resistant Infection
- Critical Illness

## Interventions

- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT03452839
- **Lead sponsor:** Università Vita-Salute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 607 (ACTUAL)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452839, "Bolus Versus Continuous Infusion of Meropenem". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03452839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*